| Literature DB >> 26755150 |
Unai Eletxigerra1, Josu Martinez-Perdiguero2, Rodrigo Barderas3, José M Pingarrón4, Susana Campuzano4, Santos Merino1.
Abstract
A highly sensitive surface plasmon resonance (SPR) immunosensor for the important ErbB2 breast cancer biomarker has been developed. Optimization of the assay has been carried out, including signal enhancement employing gold nanoparticles (GNPs). The effect of the signal amplification of the GNPs has been also studied. The assay has been tested with clinically relevant matrices. Results in 50% human serum yielded a LOD of 180 pg mL(-1) which is a concentration 83 times lower than the clinical cut-off. Raw lysates from model breast cancer cell lines (SK-BR-3, MCF-7 and MDA-MB-436) have been also assayed and higher quantities of the ErbB2 protein were clearly observed in the ErbB2 over-expressing case (SK-BR-3). The results confirmed that the simple and highly sensitive SPR immunosensor represents a feasible tool for ErbB2 detection.Entities:
Keywords: Biosensor; Cell lysates; ErbB2 biomarker; Gold nanoparticles; Serum; Surface plasmon resonance (SPR)
Mesh：
Substances：
Year: 2015 PMID： 26755150 DOI： 10.1016/j.aca.2015.12.020
Source DB: PubMed Journal: Anal Chim Acta ISSN： 0003-2670 Impact factor: 6.558